NCT05087693View on ClinicalTrials.gov

Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions

Asthma and/or Exercise Induced BronchoconstrictionOzone Air Pollution

Interventions

DRUG

Salbutamol

Inhaling 200ug of salbutamol

DRUG

Placebo medication

Inhaling placebo medication

OTHER

Ozone

Breathing 170ppb ozone

OTHER

Filtered Air

Breathing filtered air

OTHER

Exercise

Cycling at 60% of VO2max on a cycle ergometer

Trial Locations (1)

V6T 1Z1

Environmental Physiology Laboratory, Vancouver

All Listed Sponsors

lead

University of British Columbia

OTHER

NCT05087693 - Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB) | Biotech Hunter | Biotech Hunter